A possible option Joe.
However Immutep would be a pre-clinical one trick pony
Not sure how this would sit with existing and potential cornerstone investors?
761 has taken an eternity to get this far and not yet in the clinic.
Encouraging- absolutely. Treating the cause instead of current SOC treating the symptoms. Curative perhaps.
- Forums
- ASX - By Stock
- Relatlimab
A possible option Joe. However Immutep would be a pre-clinical...
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 53192 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 41048 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 51196 | 0.295 |
9 | 230902 | 0.290 |
5 | 74631 | 0.285 |
22 | 480847 | 0.280 |
4 | 114783 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 41048 | 1 |
0.310 | 25000 | 2 |
0.315 | 10525 | 1 |
0.320 | 76654 | 4 |
0.325 | 30000 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online